Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2021-04-01
2023-11-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period.
All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Research Study for Latina Women After Breast Cancer Treatment
NCT03645005
A Research Study for Latina Women Undergoing Breast Cancer Treatment
NCT04064151
A Web-Based Tool to Improve Breast Cancer Survivorship
NCT03849573
Empowering Latinas to Obtain Breast Cancer Screenings
NCT02964234
Avanzando Juntas: Adapting an Evidence Based Weight Loss Program for Hispanic Breast Cancer Survivors
NCT04321135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"My Guide" (psychoeducation & self management program)
Smartphone-based program plus standard clinical care.
"My Guide" (psychoeducation & self-management program)
12-week long health promotion Smartphone application to support patient's side effects self-management and adherence to endocrine therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"My Guide" (psychoeducation & self-management program)
12-week long health promotion Smartphone application to support patient's side effects self-management and adherence to endocrine therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of breast cancer, non-metastatic, stage 0-III (A, B, or C)
* Receiving or received endocrine/hormone therapy within the last 3 years (36 months)
* At least 18 years of age
* Able to speak and read English or Spanish
* Able to provide informed consent
* Self-identify Hispanic/Latina ethnicity
Exclusion Criteria
* Visual, hearing, voice, or motor impairment that would prevent completion of study procedures
* Diagnosis of an unmanaged psychotic disorder, bipolar disorder, dissociative disorder, or other diagnoses for which participation in this trial is either inappropriate or dangerous - this includes patients who have a life-threatening illness (e.g., end-stage kidney disease) or diagnosis of a chronic disease that is associated with a major functional impairment (e.g., fibromyalgia)
* Illicit substance or alcohol dependence
* Suicidal ideation, plan, intent
* Alzheimer's, dementia, or history of stroke
* Scheduled reconstruction surgery within 1 month of any study procedures or involvement.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Betina Yanez
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00201961B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.